Skip to Main Content

Author Details

Meaghan H Hancock
Vaccine and Gene Therapy Institute, Oregon Health & Science University
2006
37
16
PMIDPaper TitleJournal TitlePublished Year
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
37782657Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.PLoS Pathog2023
37818347mRNA vaccine against fibroblast activation protein ameliorates murine models of inflammatory arthritis.Rheumatol Immunol Res2023
37772824HCMV UL8 interaction with β-catenin and DVL2 regulates viral reactivation in CD34<sup>+</sup> hematopoietic progenitor cells.J Virol2023
37289831Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection.PLoS Pathog2023
36463091Viral miRNA regulation of host gene expression.Semin Cell Dev Biol2023
36798153Human Cytomegalovirus UL138 Interaction with USP1 Activates STAT1 in infection.bioRxiv2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
35012351Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation.mBio2022
35714200Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.Sci Immunol2022
33177198CD34<sup>+</sup> Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.J Virol2021
33766849Cytomegaloviral determinants of CD8[+] T cell programming and RhCMV/SIV vaccine efficacy.Sci Immunol2021
33824207Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34<sup>+</sup> Hematopoietic Progenitor Cell Proliferation To Maintain the Latent Viral Genome.mBio2021
33508041Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.PLoS Pathog2021
33668486Regulation of Latency and Reactivation by Human Cytomegalovirus miRNAs.Pathogens2021
33555594Techniques for Characterizing Cytomegalovirus-Encoded miRNAs.Methods Mol Biol2021
34411201Human cytomegalovirus blocks canonical TGFβ signaling during lytic infection to limit induction of type I interferons.PLoS Pathog2021
34025614Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.Front Microbiol2021
33408225Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34<sup>+</sup> Hematopoietic Progenitor Cells from Apoptosis.mSphere2021
32759334Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and <i>UL138</i> Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways.mSphere2020
31866424Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34<sup>+</sup> Hematopoietic Progenitor Cells.Cell Host Microbe2020
31431555Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34[+] Hematopoietic Progenitor Cells and Humanized NSG Mice.mBio2019
31725809HCMV miR-US22 down-regulation of EGR-1 regulates CD34+ hematopoietic progenitor cell proliferation and viral reactivation.PLoS Pathog2019
28674945Roles of Non-coding RNAs During Herpesvirus Infection.Curr Top Microbiol Immunol2018
30360396HCMV miRNA Targets Reveal Important Cellular Pathways for Viral Replication, Latency, and Reactivation.Noncoding RNA2018
29082387Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.Virology (Hyderabad)2017
28270578Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ.mBio2017
27829026Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques.PLoS Pathog2016
24629342Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion.Cell Host Microbe2014
24769092Cytomegalovirus microRNAs.Curr Opin Virol2014
24639227Techniques for characterizing cytomegalovirus-encoded miRNAs.Methods Mol Biol2014
22305624Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.Virology2012
19939931Herpes simplex virus VP16, but not ICP0, is required to reduce histone occupancy and enhance histone acetylation on viral genomes in U2OS osteosarcoma cells.J Virol2010
19038458Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production.Mol Immunol2009
19535444Cell fusion-induced activation of interferon-stimulated genes is not required for restriction of a herpes simplex virus VP16/ICP0 mutant in heterokarya formed between permissive and restrictive cells.J Virol2009
16750236Herpes simplex virus regulatory proteins VP16 and ICP0 counteract an innate intranuclear barrier to viral gene expression.Virology2006
  • 1 - 37 of 37

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 6
University of California los angeles
Career Start Year 2010
Number of shared co-authors 0
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year 2009
Number of shared co-authors 3
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 2
The Ohio State University Wexner Medical Center
Career Start Year 2009
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases
Career Start Year 2007
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 2006
Number of shared co-authors 0
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 5
Northwestern University Feinberg School of Medicine
Career Start Year 2004
Number of shared co-authors 0
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2004
Number of shared co-authors 0
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 4
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 7
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
Cancer Research Institute, Central South University
Career Start Year 1995
Number of shared co-authors 1
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 5
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 3
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 8
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 9
University of Western Ontario
Career Start Year 1992
Number of shared co-authors 0
University of California los angeles
Career Start Year 1992
Number of shared co-authors 4
University College London
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
University of Utah
Career Start Year 1991
Number of shared co-authors 4
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 3
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 12
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 2
University of Washington
Career Start Year 1978
Number of shared co-authors 8
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Career Start Year 1973
Number of shared co-authors 1

Collaborators

Oregon Health and Science University
Co-authored papers 20
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 11
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 10
University of Arizona
Co-authored papers 9
Louisiana State University
Co-authored papers 8
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 8
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 6
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 5
Vaccine and Gene Therapy Institute, Oregon Health and Sciences University
Co-authored papers 4
Co-authored papers 3
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Columbia University
Co-authored papers 3
University of Iowa
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
The Roslin Institute, The University of Edinburgh
Co-authored papers 3
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
University of Utah School of Medicine
Co-authored papers 3
University of Utah School of Medicine
Co-authored papers 3
Co-authored papers 3
University of Michigan ann arbor
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Co-authored papers 3
Rockefeller University
Co-authored papers 3
The Children's Hospital of Philadelphia
Co-authored papers 3
University of North Carolina at Chapel Hill.
Co-authored papers 3
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3